LABCORP HOLDINGS INC. Capitalized Contract Cost, Amortization
LABCORP HOLDINGS INC. (LH) reported Capitalized Contract Cost, Amortization of $2.40 million for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-04.
Discontinued › Expense Statement › Operating Expenses
us-gaap:CapitalizedContractCostAmortization · last filed 2023-05-04
- LABCORP HOLDINGS INC. capitalized contract cost, amortization for the quarter ending 2023-03-31 was $2.40M, a 22.58% decline year-over-year.
- LABCORP HOLDINGS INC. capitalized contract cost, amortization for the quarter ending 2022-12-31 was $3.30M, a 21.43% decline year-over-year.
- LABCORP HOLDINGS INC. capitalized contract cost, amortization for the quarter ending 2022-09-30 was $3.10M, a 11.43% decline year-over-year.
- LABCORP HOLDINGS INC. capitalized contract cost, amortization for the quarter ending 2022-06-30 was $2.90M, a 3.33% decline year-over-year.
- LABCORP HOLDINGS INC. capitalized contract cost, amortization for fiscal 2022 was $12.40M, a 12.68% decline from fiscal 2021.
- LABCORP HOLDINGS INC. capitalized contract cost, amortization for fiscal 2021 was $14.20M, a 40.59% increase from fiscal 2020.
- LABCORP HOLDINGS INC. capitalized contract cost, amortization for fiscal 2020 was $10.10M, a 16.09% increase from fiscal 2019.
- LABCORP HOLDINGS INC. capitalized contract cost, amortization for fiscal 2019 was $8.70M, a 97.73% increase from fiscal 2018.
| Period end | Capitalized Contract Cost, Amortization 3 month | Capitalized Contract Cost, Amortization 6 month | Capitalized Contract Cost, Amortization 9 month | Capitalized Contract Cost, Amortization 12 month |
|---|---|---|---|---|
| 2023-03-31 | $2.40M 10-Q · filed 2023-05-04 | $5.70M derived: sum of 2 quarters · filed 2023-05-04 | $8.80M derived: sum of 3 quarters · filed 2023-05-04 | $11.70M derived: sum of 4 quarters · filed 2023-05-04 |
| 2022-12-31 | $3.30M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $6.40M derived: sum of 2 quarters · filed 2023-02-28 | $9.30M derived: sum of 3 quarters · filed 2023-02-28 | $12.40M 10-K · filed 2023-02-28 |
| 2022-09-30 | $3.10M 10-Q · filed 2022-11-01 | $6.00M derived: sum of 2 quarters · filed 2022-11-01 | $9.10M 10-Q · filed 2022-11-01 | $13.30M derived: sum of 4 quarters · filed 2023-05-04 |
| 2022-06-30 | $2.90M 10-Q · filed 2022-08-01 | $6.00M 10-Q · filed 2022-08-01 | $10.20M derived: sum of 3 quarters · filed 2023-05-04 | $13.70M derived: sum of 4 quarters · filed 2023-05-04 |
| 2022-03-31 | $3.10M 10-Q · filed 2023-05-04 | $7.30M derived: sum of 2 quarters · filed 2023-05-04 | $10.80M derived: sum of 3 quarters · filed 2023-05-04 | $13.80M derived: sum of 4 quarters · filed 2023-05-04 |
| 2021-12-31 | $4.20M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $7.70M derived: sum of 2 quarters · filed 2023-02-28 | $10.70M derived: sum of 3 quarters · filed 2023-02-28 | $14.20M 10-K · filed 2023-02-28 |
| 2021-09-30 | $3.50M 10-Q · filed 2022-11-01 | $6.50M derived: sum of 2 quarters · filed 2022-11-01 | $10.00M 10-Q · filed 2022-11-01 | $12.50M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $3.00M 10-Q · filed 2022-08-01 | $6.50M 10-Q · filed 2022-08-01 | $9.00M derived: sum of 3 quarters · filed 2023-02-28 | $11.30M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $3.50M 10-Q · filed 2022-04-29 | $6.00M derived: sum of 2 quarters · filed 2023-02-28 | $8.30M derived: sum of 3 quarters · filed 2023-02-28 | $10.60M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $2.50M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $4.80M derived: sum of 2 quarters · filed 2023-02-28 | $7.10M derived: sum of 3 quarters · filed 2023-02-28 | $10.10M 10-K · filed 2023-02-28 |
| 2020-09-30 | $2.30M 10-Q · filed 2021-11-02 | $4.60M derived: sum of 2 quarters · filed 2021-11-02 | $7.60M 10-Q · filed 2021-11-02 | $10.20M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-06-30 | $2.30M 10-Q · filed 2021-08-05 | $5.30M 10-Q · filed 2021-08-05 | $7.90M derived: sum of 3 quarters · filed 2022-02-25 | $10.20M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-03-31 | $3.00M 10-Q · filed 2021-05-04 | $5.60M derived: sum of 2 quarters · filed 2022-02-25 | $7.90M derived: sum of 3 quarters · filed 2022-02-25 | $9.80M derived: sum of 4 quarters · filed 2022-02-25 |
| 2019-12-31 | $2.60M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $4.90M derived: sum of 2 quarters · filed 2022-02-25 | $6.80M derived: sum of 3 quarters · filed 2022-02-25 | $8.70M 10-K · filed 2022-02-25 |
| 2019-09-30 | $2.30M 10-Q · filed 2020-10-29 | $4.20M derived: sum of 2 quarters · filed 2020-10-29 | $6.10M 10-Q · filed 2020-10-29 | $7.10M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $1.90M 10-Q · filed 2020-07-31 | $3.80M 10-Q · filed 2020-07-31 | $4.80M derived: sum of 3 quarters · filed 2021-02-25 | $5.60M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $1.80M 10-Q · filed 2020-05-08 | $2.90M derived: sum of 2 quarters · filed 2021-02-25 | $3.70M derived: sum of 3 quarters · filed 2021-02-25 | $5.60M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $1.90M derived: sum of 2 quarters · filed 2021-02-25 | $3.80M derived: sum of 3 quarters · filed 2021-02-25 | $4.40M 10-K · filed 2021-02-25 |
| 2018-09-30 | $800.00K 10-Q · filed 2019-10-31 | $2.70M derived: sum of 2 quarters · filed 2019-10-31 | $3.30M 10-Q · filed 2019-10-31 | $3.30M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-06-30 | $1.90M 10-Q · filed 2019-08-08 | $2.50M 10-Q · filed 2019-08-08 | $2.50M derived: sum of 3 quarters · filed 2020-02-28 | $2.60M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-03-31 | $600.00K 10-Q · filed 2019-05-03 | $600.00K derived: sum of 2 quarters · filed 2020-02-28 | $700.00K derived: sum of 3 quarters · filed 2020-02-28 | $800.00K derived: sum of 4 quarters · filed 2020-02-28 |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $100.00K derived: sum of 2 quarters · filed 2020-02-28 | $200.00K derived: sum of 3 quarters · filed 2020-02-28 | $300.00K 10-K · filed 2020-02-28 |
| 2017-09-30 | $100.00K 10-Q · filed 2018-10-30 | $200.00K derived: sum of 2 quarters · filed 2018-10-30 | $300.00K 10-Q · filed 2018-10-30 | |
| 2017-06-30 | $100.00K 10-Q · filed 2018-07-27 | $200.00K 10-Q · filed 2018-07-27 | ||
| 2017-03-31 | $100.00K 10-Q · filed 2018-05-01 | |||
| 2016-12-31 | $900.00K 10-K · filed 2019-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |